video corpo

EXABLATE PROSTATE
12Pages

{{requestButtons}}

Catalog excerpts

EXABLATE PROSTATE - 1

FROM SEARCHING TO SOLUTION Exablate Prostate

Open the catalog to page 1
EXABLATE PROSTATE - 3

Harness the Therapeutic Power of Focused Ultrasound Incisionless. Precise. Life Uninterrupted. Exablate® Prostate delivers up to 1000 ultrasound waves to precisely heat and ablate Prostate tissue with no surgical incisions or radiation. Treatment is guided by MR imaging for patient-specific planning, real-time temperature monitoring as well as real-time confirmation of the ablated region. First, the clinical team will use an MRI to visualize the prostate during the entire treatment. The Exablate system utilizes specialized software to create a personalized plan to deliver energy effectively...

Open the catalog to page 3
EXABLATE PROSTATE - 4

Innovation is No Longer Cutting Edge ■ Phased array, piezoceramic transducer with up to 1000 elements Advanced focusing algorithms that can be adjusted according to patient’s anatomy helping to avoid critical structures Personalized treatment plan utilizing focused ultrasound waves at targeted tissue (lesion) MRI real-time imaging guidance allows for precise delivery of energy while sparing healthy tissue Continuous circulation of water actively cools rectum Advanced software for temperature monitoring and treatment control For specific indications for use in each country, please refer to...

Open the catalog to page 4
EXABLATE PROSTATE - 7

Transforming Patient Care Focused ultrasound treatment is performed in the MRI suite, with the treating physician sitting at a desk using MRI & Ultrasound energy to precisely plan the treatment. Tissue Sparing Preserve healthy tissue Fast return to daily life and activities MRI Guided & Temperature Control ■ Adjust treatment plan according to Prostate movements and deformations Individualize treatment to account for non-homogenous prostate tissue Precise ablation Avoid critic

Open the catalog to page 7
EXABLATE PROSTATE - 8

Identify. Treat. Protect. Patient Preparation The patient will be positioned lying on their back while under general anesthesia on the MRI table. A urinary catheter will be inserted to drain the bladder during the procedure. Patient heart rate, blood pressure and blood oxygen levels will be monitored throughout the procedure. The Exablate Prostate endorectal probe, wrapped in a single-use balloon and cooled to a temperature of 14°C will be inserted gently for treatment. Planning First, a series of MRI images will be taken for the purpose of planning the treatment. The physician will...

Open the catalog to page 8
EXABLATE PROSTATE - 9

Post Treatment After treatment, the endorectal transducer will be removed and the patient will be moved to recovery per standard of care prior to discharge. If needed, the urinary catheter will remain in the bladder for up to a week, based on the doctor’s decision. Patients may be prescribed medication to prevent potential catheter complications and, if needed, to alleviate pain.

Open the catalog to page 9
EXABLATE PROSTATE - 10

Clinical Evidence An Insightec-sponsored pivotal trial of 101 subjects, evaluating safety at 12 months and effectiveness at 6 months, showed: ■ 91% had a negative biopsy rate at 6 months 92% had no erectile dysfunction at 12 months No serious adverse events at 6 months Highest recorded adverse effects at 12 months include erectile dysfunction and urinary incontinence at 8% and 3.5%, respectively. Important Safety Information Patients and physicians should have a detailed conversation regarding risks and complications, also known as adverse events, that patients may experience. This...

Open the catalog to page 10
EXABLATE PROSTATE - 11

Potential Risks Associated with Exablate Prostate The majority of AEs reported were either mild (86.5%) or moderate (13%). There was one AE categorized as Severe for a UTI event, which resolved in less than a week. At 12 months, the most common recorded adverse events included erectile dysfunction (16%) and urinary incontinence (7%). The remaining unresolved AEs at 24 months were less than 1% and included ejaculation disorder, urinary frequency, hematospermia, urinary hesitancy, urinary urgency, prostate cyst, and urethra stricture. The number in parenthesis is the percentage of subjects...

Open the catalog to page 11
EXABLATE PROSTATE - 12

@insightec.MRgFUS @insightec @company/insightec insightec.com Insightec Ltd. © 2022. All rights reserved. PUB71007653 NA Rev. 1

Open the catalog to page 12

All InSightec catalogs and technical brochures